$NAVB FDA Approves Expanded Use of Navidea’s Lymphoseek® for Lymphatic Mapping in Solid Tumors http://ih.advfn.com/p.php?pid=nmona&article=64045430 NAVB News: Navidea Announces Rick Gonzalez as New Chief Executive Officer http://ih.advfn.com/p.php?pid=nmona&article=64046472